Search by Drug Name or NDC

    NDC 60687-0534-36 Atovaquone 750 mg/5mL Details

    Atovaquone 750 mg/5mL

    Atovaquone is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by American Health Packaging. The primary component is ATOVAQUONE.

    Product Information

    NDC 60687-0534
    Product ID 60687-534_0293429b-79ec-fa1a-e063-6394a90a21cb
    Associated GPIs 16400020001820
    GCN Sequence Number 023399
    GCN Sequence Number Description atovaquone ORAL SUSP 750 MG/5ML ORAL
    HIC3 W4K
    HIC3 Description ANTIPROTOZOAL DRUGS,MISCELLANEOUS
    GCN 34490
    HICL Sequence Number 006619
    HICL Sequence Number Description ATOVAQUONE
    Brand/Generic Generic
    Proprietary Name Atovaquone
    Proprietary Name Suffix n/a
    Non-Proprietary Name Atovaquone
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form SUSPENSION
    Route ORAL
    Active Ingredient Strength 750
    Active Ingredient Units mg/5mL
    Substance Name ATOVAQUONE
    Labeler Name American Health Packaging
    Pharmaceutical Class Antimalarial [EPC], Antiprotozoal [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA210692
    Listing Certified Through 2024-12-31

    Package

    NDC 60687-0534-36 (60687053436)

    NDC Package Code 60687-534-36
    Billing NDC 60687053436
    Package 2 TRAY in 1 CASE (60687-534-36) / 10 CUP, UNIT-DOSE in 1 TRAY (60687-534-46) / 5 mL in 1 CUP, UNIT-DOSE (60687-534-40)
    Marketing Start Date 2023-07-13
    NDC Exclude Flag N
    Pricing Information N/A